Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Lokelma
2. Sodium Zirconium Cyclosilicate
3. Zs-9 Compound
1. Uzsi 9
2. Zs-9 Compound
3. Uzsi-9
4. Unii-d652zwf066
5. Zs 9
Molecular Weight | 371.50 g/mol |
---|---|
Molecular Formula | H6Na2O9Si3Zr+2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 0 |
Exact Mass | 369.816199 g/mol |
Monoisotopic Mass | 369.816199 g/mol |
Topological Polar Surface Area | 149 Ų |
Heavy Atom Count | 15 |
Formal Charge | 2 |
Complexity | 131 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Ion Exchange Resins
High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions. (See all compounds classified as Ion Exchange Resins.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-02-16
Pay. Date : 2022-01-13
DMF Number : 36363
Submission : 2021-12-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-18
Pay. Date : 2022-03-23
DMF Number : 36413
Submission : 2022-03-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-28
Pay. Date : 2021-11-18
DMF Number : 36438
Submission : 2021-12-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-19
Pay. Date : 2022-03-17
DMF Number : 36915
Submission : 2022-03-17
Status : Active
Type : II
NDC Package Code : 65977-0132
Start Marketing Date : 2018-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38236
Submission : 2023-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-19
Pay. Date : 2022-03-17
DMF Number : 36915
Submission : 2022-03-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-28
Pay. Date : 2021-11-18
DMF Number : 36438
Submission : 2021-12-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-18
Pay. Date : 2022-03-23
DMF Number : 36413
Submission : 2022-03-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-16
Pay. Date : 2022-01-13
DMF Number : 36363
Submission : 2021-12-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38236
Submission : 2023-03-31
Status : Active
Type : II
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Sodium Zirconium Cyclosilicate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Zirconium Cyclosilicate, including repackagers and relabelers. The FDA regulates Sodium Zirconium Cyclosilicate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Zirconium Cyclosilicate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Zirconium Cyclosilicate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Zirconium Cyclosilicate supplier is an individual or a company that provides Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) or Sodium Zirconium Cyclosilicate finished formulations upon request. The Sodium Zirconium Cyclosilicate suppliers may include Sodium Zirconium Cyclosilicate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Zirconium Cyclosilicate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Zirconium Cyclosilicate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Zirconium Cyclosilicate DMFs exist exist since differing nations have different regulations, such as Sodium Zirconium Cyclosilicate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Zirconium Cyclosilicate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Zirconium Cyclosilicate USDMF includes data on Sodium Zirconium Cyclosilicate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Zirconium Cyclosilicate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Zirconium Cyclosilicate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Zirconium Cyclosilicate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Zirconium Cyclosilicate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Zirconium Cyclosilicate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Zirconium Cyclosilicate suppliers with NDC on PharmaCompass.
Sodium Zirconium Cyclosilicate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Zirconium Cyclosilicate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Zirconium Cyclosilicate GMP manufacturer or Sodium Zirconium Cyclosilicate GMP API supplier for your needs.
A Sodium Zirconium Cyclosilicate CoA (Certificate of Analysis) is a formal document that attests to Sodium Zirconium Cyclosilicate's compliance with Sodium Zirconium Cyclosilicate specifications and serves as a tool for batch-level quality control.
Sodium Zirconium Cyclosilicate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Zirconium Cyclosilicate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Zirconium Cyclosilicate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Zirconium Cyclosilicate EP), Sodium Zirconium Cyclosilicate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Zirconium Cyclosilicate USP).
LOOKING FOR A SUPPLIER?